{
  "DOI": "10.1038/s41431-024-01572-4",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-024-01572-4",
  "alternative-id": [
    "1572"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "11 August 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "30 January 2024"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "19 February 2024"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "3 April 2024"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-7797-9478",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Manson",
      "given": "Lisanne E. N.",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-7476-6867",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Nijenhuis",
      "given": "Marga",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Soree",
      "given": "Bianca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Boer-Veger",
      "given": "Nienke J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Buunk",
      "given": "Anne-Marie",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-9927-7266",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Houwink",
      "given": "Elisa J. F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Risselada",
      "given": "Arne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rongen",
      "given": "Gerard A. P. J. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Schaik",
      "given": "Ron H. N.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3965-5552",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Swen",
      "given": "Jesse J.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-1429-4789",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Touw",
      "given": "Daan J.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-2298-9924",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "van Westrhenen",
      "given": "Roos",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Deneer",
      "given": "Vera H. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guchelaar",
      "given": "Henk-Jan",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2024,
        4,
        3
      ]
    ],
    "date-time": "2024-04-03T07:02:15Z",
    "timestamp": 1712127735000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        4,
        3
      ]
    ],
    "date-time": "2024-04-03T07:05:28Z",
    "timestamp": 1712127928000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        5
      ]
    ],
    "date-time": "2024-04-05T01:01:13Z",
    "timestamp": 1712278873798
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issued": {
    "date-parts": [
      [
        2024,
        4,
        3
      ]
    ]
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            4,
            3
          ]
        ],
        "date-time": "2024-04-03T00:00:00Z",
        "timestamp": 1712102400000
      }
    },
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            4,
            3
          ]
        ],
        "date-time": "2024-04-03T00:00:00Z",
        "timestamp": 1712102400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-024-01572-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-024-01572-4",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-024-01572-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2024,
        4,
        3
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2024,
        4,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1371/journal.pmed.0040209",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "e209",
      "journal-title": "PLoS Med",
      "key": "1572_CR1",
      "unstructured": "Swen JJ, Huizinga TW, Gelderblom H, de Vries EGE, Assendelft WJJ, Kirchheiner J, et al. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med. 2007;4:e209.",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.3389/fpsyt.2020.00094",
      "author": "R van Westrhenen",
      "doi-asserted-by": "publisher",
      "first-page": "94",
      "journal-title": "Front Psychiatry",
      "key": "1572_CR2",
      "unstructured": "van Westrhenen R, Aitchison KJ, Ingelman-Sundberg M, Jukić MM. Pharmacogenomics of antidepressant and antipsychotic treatment: how far have we got and where are we going? Front Psychiatry. 2020;11:94.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1038/clpt.2011.34",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "662",
      "journal-title": "Clin Pharm Ther",
      "key": "1572_CR3",
      "unstructured": "Swen JJ, Nijenhuis M, de Boer A, Grandia L, Maitland-van der Zee AH, Mulder H, et al. Pharmacogenetics: from bench to byte—an update of guidelines. Clin Pharm Ther. 2011;89:662–73.",
      "volume": "89",
      "year": "2011"
    },
    {
      "DOI": "10.1002/cpt.1049",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "795",
      "journal-title": "Clin Pharmacol Ther",
      "key": "1572_CR4",
      "unstructured": "Swen JJ, Nijenhuis M, van Rhenen M, de Boer‐Veger NJ, Buunk AM, Houwink EJF, et al. Pharmacogenetic information in clinical guidelines: the European perspective. Clin Pharmacol Ther. 2018;103:795–801.",
      "volume": "103",
      "year": "2018"
    },
    {
      "key": "1572_CR5",
      "unstructured": "European Association for Clinical Pharmacology and Therapeutics (EACPT). 2017. https://www.eacpt.eu/."
    },
    {
      "key": "1572_CR6",
      "unstructured": "European Association of Hospital Pharmacists (EAHP). 2017. https://www.eahp.eu/."
    },
    {
      "DOI": "10.1038/s41431-023-01347-3",
      "doi-asserted-by": "crossref",
      "key": "1572_CR7",
      "unstructured": "Beunk L, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Guchelaar HJ, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics. Eur J Hum Genet. 2023;32:278–85."
    },
    {
      "DOI": "10.1038/s41431-021-01004-7",
      "author": "JMJL Brouwer",
      "doi-asserted-by": "publisher",
      "first-page": "1114",
      "journal-title": "Eur J Hum Genet",
      "key": "1572_CR8",
      "unstructured": "Brouwer JMJL, Nijenhuis M, Soree B, Guchelaar HJ, Swen JJ, van Schaik RHN, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs. Eur J Hum Genet. 2022;30:1114–20.",
      "volume": "30",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41431-022-01243-2",
      "author": "EC Hulshof",
      "doi-asserted-by": "publisher",
      "first-page": "982",
      "journal-title": "Eur J Hum Genet",
      "key": "1572_CR9",
      "unstructured": "Hulshof EC, Deenen MJ, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan. Eur J Hum Genet. 2023;31:982–7.",
      "volume": "31",
      "year": "2023"
    },
    {
      "DOI": "10.1038/s41431-019-0540-0",
      "author": "CATC Lunenburg",
      "doi-asserted-by": "publisher",
      "first-page": "508",
      "journal-title": "Eur J Hum Genet",
      "key": "1572_CR10",
      "unstructured": "Lunenburg CATC, van der Wouden CH, Nijenhuis M, Crommentuijn-van Rhenen MH, de Boer-Veger NJ, Buunk AM, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of DPYD and fluoropyrimidines. Eur J Hum Genet. 2020;28:508–17.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41431-021-00920-y",
      "author": "M Matic",
      "doi-asserted-by": "publisher",
      "first-page": "1105",
      "journal-title": "Eur J Hum Genet",
      "key": "1572_CR11",
      "unstructured": "Matic M, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Houwink EJF, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone). Eur J Hum Genet. 2022;30:1105–13.",
      "volume": "30",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41431-022-01262-z",
      "author": "M Nijenhuis",
      "doi-asserted-by": "publisher",
      "first-page": "1364",
      "journal-title": "Eur J Hum Genet",
      "key": "1572_CR12",
      "unstructured": "Nijenhuis M, Soree B, Jama WOM, de Boer-Veger NJ, Buunk AM, Guchelaar HJ, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate. Eur J Hum Genet. 2023;31:1364–70.",
      "volume": "31",
      "year": "2023"
    },
    {
      "DOI": "10.1038/s41431-022-01180-0",
      "author": "KH van der Pol",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Eur J Hum Genet",
      "key": "1572_CR13",
      "unstructured": "van der Pol KH, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Guchelaar HJ, et al. Dutch Pharmacogenetics Working Group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate. Eur J Hum Genet. 2024;32:155–62.",
      "volume": "32",
      "year": "2024"
    },
    {
      "DOI": "10.2217/pgs.14.65",
      "author": "KM Bloch",
      "doi-asserted-by": "publisher",
      "first-page": "857",
      "journal-title": "Pharmacogenomics",
      "key": "1572_CR14",
      "unstructured": "Bloch KM, Sills GJ, Pirmohamed M, Alfirevic A. Pharmacogenetics of antiepileptic drug-induced hypersensitivity. Pharmacogenomics. 2014;15:857–68.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1212/01.WNL.0000156354.20227.F0",
      "author": "M Mockenhaupt",
      "doi-asserted-by": "publisher",
      "first-page": "1134",
      "journal-title": "Neurology",
      "key": "1572_CR15",
      "unstructured": "Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology. 2005;64:1134–8.",
      "volume": "64",
      "year": "2005"
    },
    {
      "key": "1572_CR16",
      "unstructured": "GlaxoSmithKline BV. Lamictal (lamotrigine): full prescribing information. GlaxoSmithKline; 2009."
    },
    {
      "key": "1572_CR17",
      "unstructured": "US Food and Drug Administration. Official drug label: Trileptal (oxcarbazepine). 2009."
    },
    {
      "key": "1572_CR18",
      "unstructured": "NCBI. CYP2C9 cytochrome P450 family 2 subfamily C member 9 [Homo sapiens (human)]. https://www.ncbi.nlm.nih.gov/gene/1559."
    },
    {
      "DOI": "10.1016/j.jmoldx.2019.04.003",
      "author": "VM Pratt",
      "doi-asserted-by": "publisher",
      "first-page": "746",
      "journal-title": "J Mol Diagn",
      "key": "1572_CR19",
      "unstructured": "Pratt VM, Cavallari LH, Del Tredici AL, Hachad H, Ji Y, Moyer AM, et al. Recommendations for clinical CYP2C9 genotyping allele selection: a joint recommendation of the Association for Molecular Pathology and College of American Pathologists. J Mol Diagn. 2019;21:746–55.",
      "volume": "21",
      "year": "2019"
    },
    {
      "key": "1572_CR20",
      "unstructured": "Genbank. Homo sapiens MHC class I antigen (HLA) mRNA, HLA-A*3101 allele, complete cds. https://www.ncbi.nlm.nih.gov/nuccore/M84375.1."
    },
    {
      "key": "1572_CR21",
      "unstructured": "Genbank. Homo sapiens mRNA for HLA-B*1502, complete cds. https://www.ncbi.nlm.nih.gov/nuccore/D50293.1."
    },
    {
      "key": "1572_CR22",
      "unstructured": "Genbank. Homo sapiens mRNA for HLA-B*1511, complete cds. https://www.ncbi.nlm.nih.gov/nuccore/D50294.1."
    },
    {
      "DOI": "10.1002/cpt.2350",
      "doi-asserted-by": "crossref",
      "key": "1572_CR23",
      "unstructured": "Whirl-Carrillo M, Huddart R, Gong L, Sangkuhl K, Thorn CF, Whaley R, et al. An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2021;110:563–72."
    },
    {
      "DOI": "10.1097/FPC.0b013e32834aeedb",
      "doi-asserted-by": "crossref",
      "key": "1572_CR24",
      "unstructured": "Thorn CF, Whirl-Carrillo M, Leeder JS, Klein TE, Altman RB. PharmGKB summary: phenytoin pathway. Pharmacogenet Genomics. 2012;22:466–70."
    },
    {
      "DOI": "10.1038/sj.clpt.6100507",
      "author": "J Swen",
      "doi-asserted-by": "publisher",
      "first-page": "781",
      "journal-title": "Clin Pharmacol Ther",
      "key": "1572_CR25",
      "unstructured": "Swen J, Wilting I, de Goede A, Grandia L, Mulder H, Touw D, et al. Pharmacogenetics: from bench to byte. Clin Pharmacol Ther. 2008;83:781–7.",
      "volume": "83",
      "year": "2008"
    },
    {
      "key": "1572_CR26",
      "unstructured": "Royal Dutch Pharmacists Association (KNMP): pharmacogenetic recommendation text. 2023. https://www.knmp.nl/."
    },
    {
      "DOI": "10.1038/s41397-021-00249-1",
      "author": "K Karamperis",
      "doi-asserted-by": "publisher",
      "first-page": "533",
      "journal-title": "Pharmacogenomics J",
      "key": "1572_CR27",
      "unstructured": "Karamperis K, Koromina M, Papantoniou P, Skokou M, Kanellakis F, Mitropoulos K, et al. Economic evaluation in psychiatric pharmacogenomics: a systematic review. Pharmacogenomics J. 2021;21:533–41.",
      "volume": "21",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fphar.2019.00830",
      "author": "S Simeonidis",
      "doi-asserted-by": "publisher",
      "first-page": "830",
      "journal-title": "Front Pharm",
      "key": "1572_CR28",
      "unstructured": "Simeonidis S, Koutsilieri S, Vozikis A, Cooper DN, Mitropoulou C, Patrinos GP. Application of economic evaluation to assess feasibility for reimbursement of genomic testing as part of personalized medicine interventions. Front Pharm. 2019;10:830.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1002/cpt.762",
      "author": "P Bank",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "journal-title": "Clin Pharmacol Ther",
      "key": "1572_CR29",
      "unstructured": "Bank P, Caudle K, Swen J, Gammal R, Whirl‐Carrillo M, Klein T, et al. Comparison of the guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group. Clin Pharmacol Ther. 2018;103:599–618.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.3389/fphar.2020.595219",
      "author": "H Abdullah-Koolmees",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Pharm",
      "key": "1572_CR30",
      "unstructured": "Abdullah-Koolmees H, van Keulen AM, Nijenhuis M, Deneer VHM. Pharmacogenetics guidelines: overview and comparison of the DPWG, CPIC, CPNDS, and RNPGx guidelines. Front Pharm. 2020;11:595219.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1002/cpt.2008",
      "author": "JH Karnes",
      "doi-asserted-by": "publisher",
      "first-page": "302",
      "journal-title": "Clin Pharmacol Ther",
      "key": "1572_CR31",
      "unstructured": "Karnes JH, Rettie AE, Somogyi AA, Huddart R, Fohner AE, Formea CM, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C9 and HLA-B genotypes and phenytoin dosing: 2020 update. Clin Pharmacol Ther. 2021;109:302–9.",
      "volume": "109",
      "year": "2021"
    },
    {
      "DOI": "10.1002/cpt.1004",
      "author": "EJ Phillips",
      "doi-asserted-by": "publisher",
      "first-page": "574",
      "journal-title": "Clin Pharmacol Ther",
      "key": "1572_CR32",
      "unstructured": "Phillips EJ, Sukasem C, Whirl‐Carrillo M, Müller DJ, Dunnenberger HM, Chantratita W, et al. Clinical Pharmacogenetics Implementation Consortium guideline for HLA genotype and use of carbamazepine and oxcarbazepine: 2017 update. Clin Pharmacol Ther. 2018;103:574–81.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1111/epi.12564",
      "author": "U Amstutz",
      "doi-asserted-by": "publisher",
      "first-page": "496",
      "journal-title": "Epilepsia",
      "key": "1572_CR33",
      "unstructured": "Amstutz U, Shear NH, Rieder MJ, Hwang S, Fung V, Nakamura H, et al. Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions. Epilepsia. 2014;55:496–506.",
      "volume": "55",
      "year": "2014"
    }
  ],
  "reference-count": 33,
  "references-count": 33,
  "relation": {
    "has-preprint": [
      {
        "asserted-by": "object",
        "id": "10.21203/rs.3.rs-3255043/v1",
        "id-type": "doi"
      }
    ]
  },
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-024-01572-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy"
}